Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.
Br J Surg. 2012 Feb;99(2):232-7. doi: 10.1002/bjs.7703. Epub 2011 Oct 24.
Selective digestive decontamination (SDD) and selective oropharyngeal decontamination (SOD) are effective in improving survival in patients under intensive care. In this study possible differential effects in surgical and non-surgical patients were investigated.
This was a post hoc subgroup analysis of data from a cluster-randomized multicentre trial comparing three groups (SDD, SOD or standard care) to quantify effects among surgical and non-surgical patients. The primary study outcome was 28-day mortality rate. Duration of mechanical ventilation, duration of intensive care unit (ICU) and hospital length of stay, and bacteraemia rates were secondary outcomes.
The subgroup analyses included a total of 2762 surgical and 3165 non-surgical patients. Compared with standard care, adjusted odds ratios (ORs) for mortality were comparable in SDD-treated surgical and non-surgical patients: 0·86 (95 per cent confidence interval 0·69 to 1·09; P = 0·220) and 0·85 (0·70 to 1·03; P = 0·095) respectively. However, duration of mechanical ventilation, ICU stay and hospital stay were significantly reduced in surgical patients who had SDD. SOD did not reduce mortality compared with standard treatment in surgical patients (adjusted OR 0·97, 0·77 to 1·22; P = 0·801); in non-surgical patients it reduced mortality (adjusted OR 0·77, 0·63 to 0·94; P = 0·009) by 16·6 per cent, representing an absolute mortality reduction of 5·5 per cent with number needed to treat of 18.
Subgroup analysis found similar effects of SDD in reducing mortality in surgical and non-surgical ICU patients, whereas SOD reduced mortality only in non-surgical patients. The hypothesis-generating findings mandate investigation into mechanisms between different ICU populations.
选择性消化道去污染(SDD)和选择性口咽部去污染(SOD)可有效提高重症监护患者的生存率。本研究旨在探讨其在外科和非外科患者中的可能差异。
这是一项针对一项多中心、集群随机对照试验数据的事后亚组分析,该试验比较了 SDD、SOD 和标准治疗三组,以量化外科和非外科患者的治疗效果。主要研究终点为 28 天死亡率。次要研究终点为机械通气时间、重症监护病房(ICU)入住时间、住院时间和菌血症发生率。
亚组分析共纳入 2762 例外科和 3165 例非外科患者。与标准治疗相比,SDD 治疗的外科和非外科患者死亡率的校正比值比(OR)相似:0.86(95%可信区间 0.69 至 1.09;P=0.220)和 0.85(0.70 至 1.03;P=0.095)。然而,SDD 可显著缩短外科患者的机械通气时间、ICU 入住时间和住院时间。与标准治疗相比,SOD 并未降低外科患者的死亡率(校正 OR 0.97,0.77 至 1.22;P=0.801);但可降低非外科患者的死亡率(校正 OR 0.77,0.63 至 0.94;P=0.009),降低幅度为 16.6%,绝对死亡率降低 5.5%,治疗需人数为 18。
亚组分析发现 SDD 降低外科和非外科 ICU 患者死亡率的效果相似,而 SOD 仅降低非外科患者的死亡率。这些产生假说的发现需要进一步研究不同 ICU 人群之间的机制。